Futura Medical (LON:FUM) Stock Jumps 10.6% – Here’s Why

Futura Medical plc (LON:FUM) rose 10.6% during trading on Friday. The company traded as high as GBX 0.24 and last traded at GBX 0.21. 30,022,066 shares changed hands during mid-day trading, an increase of 182% from the average daily volume of 10,637,467 shares. The stock had previously closed at GBX 0.19.

Futura Medical Trading Up 10.6%

The firm’s fifty day moving average price is GBX 0.22 and its 200 day moving average price is GBX 0.70. The firm has a market capitalization of £3.10 million, a PE ratio of -0.26 and a beta of 0.02.

Futura Medical (LON:FUM) last posted its earnings results on Tuesday, September 1st. The company reported GBX (0.20) earnings per share for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. On average, analysts predict that Futura Medical plc will post 2.85 earnings per share for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.